يشرفني ان اعلن عن تعييني نائبًا لرئيس الكليه الامريكيه لامراض القلب ACC و اتطلع الى مواصله الاسهام في تطوير طب القلب عالميا خلال رئاستي لتحقيق رؤيه الكليه لتعزيز جودة الرعايه القلبيه American College of Cardiology أخبار السعودية وزارة الصحة السعودية أول سعوديـ/ـة | First🥇Saudi نوابغ العرب صحيفة سبق الإلكترونية #ACC

Honored to contribute to the 2025 IM Intern Handbook at ChicagoMedicalSchool , a resource created to guide IM trainees across the nation through the challenges of intern year. I am grateful to my PD and colleagues who contributed to the project's success. mchenryresidency.nm.org/uploads/1/2/6/…

Inflammation is a 🔑 driver of atherosclerosis, independent of cholesterol. Dr Fatima Rodriguez summarized what we know about inflammation and ASCVD 🫀 #ASPC2025 ASPC #FacesofCVPrevention

JUST OUT! Critical teaching publication in #JACCCaseReports JACC Journals on how to image #AorticStenosis on Transthoracic Echo! For all sonographers, trainees, physicians! Available online for FREE! This will be the first of a series of How We Did It teaching papers with

Heart failure prevention: 🫀 Effective BP lowering 🫀 Early initiation of SGLT2i 🫀 Lifestyle modification 👑 🫀 Use the PREVENT score to give insight 🫀 CKM predisposes to HF and all CVD We need to precisely identify and target those at the very early stages of HF Dr Clyde

Dr. Mantzoros presenting on the next frontier of tx of obesity #ASPC2025 ♥️MASLD: 1/3 have this! Excess fat in the liver needs to be diagnosed ♥️Associated with CVD outcomes ♥️acquiring understanding of mechanisms ♥️✅ FIB-4 index: often in EHR

#ASPC2025 Christine Albert presents on the intersection of #Afib & #CVPrev ♥️ Afib is preventable with RF control 🫀Control of Weight, BP etc in AF guidelines for #AFibPrevention ♥️Omega-3FA & VitD don’t prevent AFib 🫀SGLT2i may ⤵️ AFib ♥️Role of AI with EVG may predict AFib

Medication Reconciliation crucial to care delivery. We focus on inertia of tx, yes, it's important that meds pts are or are not taking needs to be documented. a. drug-drug interactions b. assumptions pts are or are not on meds c. opportunity for education #ASPC2025 ASPC

💊 Pill Power: 50 mg Oral Semaglutide Delivers Big Weight Loss — OASIS‑2 Trial - - - 📍 JAMA Internal Medicine, Aug 4 2025 — 68‑week, double‑blind RCT in Japan & South Korea. Dose: Once‑daily oral semaglutide 50 mg vs placebo + lifestyle support. Population: Adults with

Amazing to see this new set of guidelines out with advances including earlier treatment, focus on sex-specific BP risk before, during, and after pregnancy, and PREVENT risk for total CVD (ASCVD+HF) >=7.5%. Kudos to the leadership team, AHA/ACC, and JCCPG staff NM Cardiovascular

Honored to share that 6 of our abstracts were accepted at #AHA2025. Looking forward to meeting and connecting with the scientific community. See you in New Orleans!!